Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 570.4M
Gross Profit 514.5M 90.20%
Operating Income 230.1M 40.34%
Net Income 223.2M 39.13%

Balance Sheet Metrics

Total Assets 1.3B
Total Liabilities 181.7M
Shareholders Equity 1.1B
Debt to Equity 0.17

Cash Flow Metrics

Operating Cash Flow 279.9M
Free Cash Flow 266.7M

Revenue & Profitability Trend

Doximity Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 570.4M 475.4M 419.1M 343.5M 206.9M
Cost of Goods Sold 55.9M 50.7M 53.5M 39.8M 31.2M
Gross Profit 514.5M 424.8M 365.6M 303.8M 175.7M
Research & Development 93.0M 82.0M 80.2M 62.4M 43.9M
Selling, General & Administrative 191.4M 171.0M 160.3M 127.9M 78.5M
Other Operating Expenses 0 0 0 0 0
Total Operating Expenses 284.4M 252.9M 240.5M 190.2M 122.4M
Operating Income 230.1M 171.8M 125.1M 113.5M 53.3M
Pre-tax Income 263.6M 185.2M 133.2M 114.0M 57.8M
Income Tax 40.4M 37.6M 20.3M -40.8M 7.6M
Net Income 223.2M 147.6M 112.8M 154.8M 50.2M
EPS (Diluted) - $0.72 $0.53 $0.70 $0.12

Income Statement Trend

Doximity Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 1.1B 912.9M 975.5M 904.1M 209.4M
Non-Current Assets 175.7M 166.4M 161.4M 87.2M 42.3M
Total Assets 1.3B 1.1B 1.1B 991.4M 251.7M
Liabilities
Current Liabilities 156.3M 147.2M 139.5M 111.3M 102.0M
Non-Current Liabilities 25.4M 30.7M 31.3M 1.5M 82.9M
Total Liabilities 181.7M 178.0M 170.8M 112.8M 185.0M
Equity
Total Shareholders Equity 1.1B 901.4M 966.1M 878.6M 66.7M

Balance Sheet Composition

Doximity Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 223.2M 147.6M 112.8M 154.8M 50.2M
Operating Cash Flow 279.9M 209.4M 178.8M 130.1M 88.8M
Investing Activities
Capital Expenditures 0 -147.0K -1.7M -1.9M -245.0K
Investing Cash Flow -22.8M 36.8M -55.4M -636.8M -66.1M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -154.4M -292.9M -89.1M 546.4M -3.5M
Free Cash Flow 266.7M 178.3M 173.4M 120.9M 78.4M

Cash Flow Trend

Doximity Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 52.23
Forward P/E 48.72
Price to Book 10.12
Price to Sales 19.09
PEG Ratio 48.72

Profitability Ratios

Profit Margin 39.13%
Operating Margin 35.32%
Return on Equity 22.50%
Return on Assets 12.31%

Financial Health

Current Ratio 6.97
Debt to Equity 1.15
Beta 1.32

Per Share Data

EPS (TTM) $1.11
Book Value per Share $5.73
Revenue per Share $3.05

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
docs 10.9B 52.23 10.12 22.50% 39.13% 1.15
Veeva Systems 46.0B 59.92 7.39 14.06% 27.34% 1.24
Ge Healthcare 32.6B 14.95 3.55 26.44% 11.03% 97.52
Tempus AI 11.4B -10.55 34.99 -1,324.71% -88.27% 262.96
HealthEquity 8.8B 73.94 4.14 5.77% 9.80% 52.11

Financial data is updated regularly. All figures are in the company's reporting currency.